Emergent BioSolutions Inc.

Healthcare

NYSE:EBS · New York Stock Exchange

Market Cap $432.89M Beta 2.33 P/E (TTM) -50.2

$8.32 -0.83%

-$0.07 today

52W Low $5.62High $14.06

Vol 0.40M · Avg 0.75M

EPS (TTM)-$0.17

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+33.12%

Period High

$13.90

Period Low

$5.63

Latest

$8.32

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

COMPASS Pathways plc

NASDAQ:CMPS

$1.16B

Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

$1.00B

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

$862.12M

Esperion Therapeutics, Inc.

NASDAQ:ESPR

$654.91M

Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

$607.79M

Prothena Corporation plc

NASDAQ:PRTA

$431.91M

Aquestive Therapeutics, Inc.

NASDAQ:AQST

$414.11M

SNDL Inc.

NASDAQ:SNDL

$369.44M

SIGA Technologies, Inc.

NASDAQ:SIGA

$309.85M

Organogenesis Holdings Inc.

NASDAQ:ORGO

$301.10M

What is the latest EBS filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does EBS have?

Intrinsic Alpha currently shows 20 recent filings for EBS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.